0.86 USD
▲+0.04+1.53%
盘后 0.87 +2.52%
2026-08-03
市值
$26.57M
市盈率
—
EPS
-4.46
股息率
—
52 周区间
0.74 – 8.08
成交量
457.41K
Beta
0.27
目标价
14.00
52W 低 0.7452W 高 8.08
价格走势
公司简介
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally dissolving sublingual film formulation of dexmede...